Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...

Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...

When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...

The experience of the GT3 Sport Cabriolet is only enhanced by the power-operated roof, but the big challenge will likely be ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

The 55th Annual Conference of the Fraunhofer Institute for Chemical Technology ICT, titled “Energetic Materials: From Simulation and Synthesis to Application – Ensuring Supply Security in a Changing ...

Researchers at Texas A&M University reported that two intranasal doses of extracellular vesicles derived from human neural ...

Multi-Waveform Wireless Prototype Will Deliver Operational Aerial Surveillance and Response ISAC is a mission-first ...

Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.

A deep reinforcement learning framework optimizes silicon-based photonic crystal fiber modulators, achieving ultra-low ...